Click Here to Go Directly to the Story
Register/Subscribe
Home


 
 


U.S. EDITION
Full Table of Contents
Cover Story
Up Front
Readers Report
Corrections & Clarifications
Books
Technology & You
Economic Viewpoint
Economic Trends
Industry Insider
Business Outlook

News: Analysis & Commentary
In Business This Week
Washington Outlook
International Business
People
Special Report -- BW/Architectural Record Awards
Developments to Watch
Science & Technology
Finance
Industrial Management

The Corporation
Information Technology
BusinessWeek Lifestyle
BusinessWeek Investor
The Barker Portfolio
Inside Wall Street
Figures of the Week
Editorials

SMALL BIZ SUPPLEMENT November 5 Table of Contents


INTERNATIONAL EDITIONS
International -- Asian Cover Story
International -- Letter From Paris
International -- Readers Report
International -- Asian Business
International -- European Business
International -- Special Report
International -- Int'l Figures of the Week




NOVEMBER 5, 2001

INSIDE WALL STREET

Sniffing Out Bombs

 
By Gene G. Marcial
Gene Marcial

  STORY TOOLS
Printer-Friendly Version
E-Mail This Story

Related Items Chart: Just Strolling Along


INSIDE WALL STREET

Sniffing Out Bombs

John Malone's Next Call: Net2Phone

Avant: Set to Make an Anthrax Vaccine

Inside Wall Street Archive

Looking for a big-cap company that makes money--and is also an anti-terrorism play? Stake out Thermo Electron (TMO ), a maker of biomedical equipment, analytical instruments, and processing machinery for the paper and recycling industries.

Catching investors' attention in particular are its devices that sniff out explosives. The only sizable buyers of such gizmos prior to September 11 were Israel and Britain. In the U.S., the big airports had them, but funds were not forthcoming to equip every terminal. Now, all that has changed. Demand for the bomb detectors has shot up: Last year's sales of $15 million are expected to balloon to $75 million next year, figures Dennison Veru of Palisades Capital Management, which has snapped up Thermo, now at 21 a share. "We have a rolling target for the stock because of the terrorism factor," says Veru, who sees the price rising to 29 in a year.

If other anti-terrorism products from Thermo catch on, he says, the stock could shoot higher still. For example, its life sciences unit produces a detection kit for anthrax. The business is still quite small but, adds Veru, "it could grow rapidly with the war against bioterrorism." Management, he adds, is keeping silent about the details--as requested by Uncle Sam. Of Thermo's $2.2 billion revenues, $900 million comes from the unit that makes explosives-detection gear, $800 million from life sciences, and $500 million from the electro-optical unit, which makes laser systems. Veru thinks that, based on its current operations, Thermo should earn 90 cents a share in 2001 and $1.07 in 2002.



By Gene G. Marcial



Get BusinessWeek directly on your desktop with our RSS feeds.XML

Add BusinessWeek news to your Web site with our headline feed.

Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video.

To subscribe online to BusinessWeek magazine, please click here.

Learn more, go to the BusinessWeekOnline home page

Back to Top

NOVEMBER
TODAY'S MOST POPULAR STORIES

  1. Oracle's Sun Deal: Oracle May Need to Loosen Its Grip
  2. Stocks: Five Market Mistakes to Avoid
  3. The Cars You Won't See in the U.S.
  4. Why This Real Estate Bust Is Different
  5. Picks of the Week: Berkshire, Starbucks, Cisco, MasterCard

Get Free RSS Feed >>
  MARKET INFO
DJIA 10226.94 +203.52
S&P 500 1093.08 +23.78
Nasdaq 2154.06 +41.62

Portfolio Service Update

Stock Lookup

Enter name or ticker



Media Kit | Special Sections | MarketPlace | Knowledge Centers
McGraw-Hill Cos.